Edition:
United Kingdom

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

168.40SEK
11:13am BST
Change (% chg)

-3.60kr (-2.09%)
Prev Close
172.00kr
Open
173.00kr
Day's High
175.00kr
Day's Low
167.60kr
Volume
21,203
Avg. Vol
49,500
52-wk High
204.00kr
52-wk Low
119.80kr

Summary

Name Age Since Current Position

Gosta Johannesson

60 2018 Chairman of the Board

Magnus Nilsson

63 2016 Chief Executive Officer

Christoffer Rosenblad

44 2017 Deputy Chief Executive Officer, Chief Financial Officer

Henrik Isaksson

48 2018 Operations Director

Emur Jensen

47 2016 Development Director

Par-Ola Larsson

50 2016 Marketing and Sales Director Europe, Middle East, Africa and Pacific

Yvonne Martensson

66 2018 Director

Alan Raffensperger

59 2018 Director

Folke Nilsson

69 Independent Director

Camilla Oberg

55 2016 Independent Director

Biographies

Name Description

Gosta Johannesson

Mr. Gosta E. Johannesson has served as Chairman of the Board of Directors at Xvivo Perfusion AB since April 27, 2018. He has previously been Director of the Company. He holds Master of Science in Business Administration and Economics from Uppsala Universitet. He is senior advisor at Bure Equity AB. His other board assignments include Vice Chairman of the Board in Interflora AB and Axiell Group as well as Chairman of the Board of Idevall & Partners Fonder AB, and Board Member in Yubico AB, among others. He was earlier Partner at Provider Venture Partners, before that held executive position at Ohman Fondkommission and Handelsbanken Markets.

Magnus Nilsson

Dr. Magnus Nilsson has served as Chief Executive Officer (CEO) of Xvivo Perfusion AB since 2011. He no longer serves as Member of the Board of Directors of the Company, effective as of May 3, 2016. Before that, he had served as CEO in Vitrolife since 2003. Previously, he was Project Leader for preclinical and clinical development at KaroBio AB and Pharmacia & Upjohn AB. He holds a Doctorate of Medical Sciences degree from Uppsala Universitet.

Christoffer Rosenblad

Mr. Christoffer Rosenblad has served as Chief Financial Officer at Xvivo Perfusion AB since 2012 and has been Deputy Chief Executive Officer of the Company since July 17, 2017. Previously, he was Business Controller at Ciba Vision Nordic AB, and before that he held financial positions at LG Electronics. He holds Master of Science degree in Mechanical Engineering from Chalmers Tekniska Hogskola and Bachelor of Science degree in Economics from Goteborgs Universitet.

Henrik Isaksson

Mr. Henrik Isaksson has served as Operations Director at Xvivo Perfusion Aktiebolag since 2018. He holds B. Sc. Business and Economics with additional graduate studies in Business. Previously, he was Senior Manager Sourcing and Supply Chain at Stryker and before that Product Manager and Supply Manager positions at Ericsson and Gambro.

Emur Jensen

Mr. Emur Jensen has been appointed Development Director at Xvivo Perfusion AB, effective as of January 1, 2016. He has almost 20 years’ experience of leading positions within the development and manufacturing of medical technology products. Over the past three years Emur has been responsible for development of the XPS. He was previously plant manager at Vitrolife Inc. and before that he was responsible for technology- and process development at C&MI Inc. He holds a Bachelor of Science degree in Chemical Engineering. He has professional Engineer license in Colorado.

Par-Ola Larsson

Mr. Par-Ola Larsson has been appointed Marketing and Sales Director Europe, Middle East, Africa and Pacific at Xvivo Perfusion Aktiebolag, effective as of January 1, 2016. He has many years’ experience of leading positions in the medical technology industry within sales, marketing and business development at companies such as Boston Scientific Inc. and Johnson & Johnson. He has been operative in the clinical areas of pulmonology, gastrology, thorax, sports medicines and neurovascular. He holds Master of Science degree in Economics and Business Administration from Handelskogskolan, Goteborgs Universitet and studied Management at Copenhagen Business School.

Yvonne Martensson

Ms. Yvonne Martensson has been Director of Xvivo Perfusion Aktiebolag since April 27, 2018. She holds M. Sc. Ind. Eng. She is Independent Board Director and Business Advisor. She is also Chairman of the board in Elos Medtech AB, board member in Biotage AB, SyntheticMR AB and 3Brain AG. She has more than thirty years experience from leading positions in fast growing companies primarily within medtech and diagnostic. Earlier CEO for CellaVision AB during 1998-2014.

Alan Raffensperger

Mr. Alan Raffensperger has been Director of Xvivo Perfusion Aktiebolag since April 27, 2018. He holds MBA from George Washington University and a B.Sc. in Health Services Management from University of Maryland Baltimore. He is CEO Inceptua SA. He has more than thirty years experience from leading positions in fast growing companies primarily within biotech, medical device and diagnostics. Previously, he was COO for SOBI (Swedish Orphan Biovitrum AB) during 2012-2017 and before that, during 2010-2012, CEO for Benechill Inc.

Folke Nilsson

Mr. Folke Nilsson serves as Independent Member of the Board of Directors of Xvivo Perfusion AB. He is Medical Doctor and holds Doctorate in Philosophy degree from University of Gothenburg. He is specialist in cardiothoracic surgery. He was earlier responsible for Heart and Lung transplantation at Sahlgrenska Universitetssjukhuset. He is general practitioner.

Camilla Oberg

Ms. Camilla Oberg has been Independent Director of Xvivo Perfusion Aktiebolag since May 3, 2016. She holds Master of Science in Economics and Business Administration from Stockholm School of Economics. She has been CFO at Cybercom Group from 2012 and before that CFO in Logica Sweden. Before that, she held management positions in WM-data, SEB, Lexicon and Swegro Group. She is Board Member of WeSC AB.